Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37

PURPOSE: Staphylococcus aureus is the most common persistent pathogen in humans, so development of new formulations to combat pathogen invasion is quite necessary. METHODS: In the current study, for the first time, the synergistic activity of recombinant lysostaphin and LL-37 peptide was studied aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Somayeh, Bakhshandeh, Haleh, Ahangari Cohan, Reza, Peirovi, Afshin, Ehsani, Parastoo, Norouzian, Dariush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911324/
https://www.ncbi.nlm.nih.gov/pubmed/31849468
http://dx.doi.org/10.2147/IJN.S230269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911324/
https://www.ncbi.nlm.nih.gov/pubmed/31849468
http://dx.doi.org/10.2147/IJN.S230269

Ejemplares similares